1. Gao, Kun, Shi, Qing, Gu, Ye, Wang, Chenji, Wan, Xiaoping. 2022. SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis. In Cell death and differentiation, 30, 475-487. doi:10.1038/s41418-022-01097-7. https://pubmed.ncbi.nlm.nih.gov/36481790/
2. Shi, Qing, Jin, Xiaofeng, Zhang, Pingzhao, Gao, Kun, Wang, Chenji. 2022. SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer. In Cell death and differentiation, 29, 1228-1239. doi:10.1038/s41418-021-00913-w. https://pubmed.ncbi.nlm.nih.gov/34987184/
3. Ali, Asgar, Sharma, Abhay Kumar, Mishra, Pramod Kumar, Saluja, Sundeep Singh. 2023. Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population. In Molecular genetics and genomics : MGG, 298, 1087-1105. doi:10.1007/s00438-023-02029-x. https://pubmed.ncbi.nlm.nih.gov/37289229/
4. Geng, Chuandong, Zhang, Man-Chao, Manyam, Ganiraju C, Pilié, Patrick G, Thompson, Timothy C. . SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. In Clinical cancer research : an official journal of the American Association for Cancer Research, 29, 4464-4478. doi:10.1158/1078-0432.CCR-23-1439. https://pubmed.ncbi.nlm.nih.gov/37581614/
智鼠故事 
